Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Stevens Institute of Technology Team Named Finalist in 2017 Collegiate Inventors Competition

Hoboken, NJ, October 17, 2017 — A Stevens Institute of Technology Senior Design team has been named one of only six undergraduate finalists for the 2017 Collegiate Inventors Competition, which honors the nation’s top collegiate inventors.

The students devised CerebroSense, a device that can monitor and measure exposed brain tissue from a distance, which reduces complications during and after open-brain surgery.

The Senior Design team, who have all graduated, includes David Ferrara, Andrew Falcone and Maria De Abreu Pineda. Continue reading

The College of New Jersey Cuts Ribbon on $76 Million, State-of-the-Art STEM Complex

Ewing, NJ, October 17, 2017 — New Jersey Governor Chris Christie, New Jersey Senate President Stephen M. Sweeney, Ewing Mayor Bert Steinmann, and The College of New Jersey President R. Barbara Gitenstein took part in a ribbon cutting ceremony on October 12 to officially open the college’s new, state-of-the-art STEM building, Chemistry addition, and Forum.

The cost of the project, which broke ground in July 2015, was $76,211,000, including $40 million provided through the Building Our Future Bond.

An additional $1.075 million in funding came from the New Jersey Higher Education Technology Infrastructure Fund. The college funded the balance through a variety of sources, including philanthropy. Continue reading

HINJ Hosts Life Sciences Celebration 2017; Honors Six for Meritorious Contributions

New Brunswick, NJ, October 13, 2017 ― Celebrating its 20th anniversary, the HealthCare Institute of New Jersey (HINJ) yesterday morning honored four individuals, a nonprofit patient advocacy organization and a public high school for their meritorious contributions in public service, medical innovation/human health, patient access/advocacy and STEM education.

The recipients of HINJ’s fifth annual honors — presented at the Historic Trenton Masonic Temple — were:

The Honorable Bob Franks Public Service Award

The Honorable Diane Allen
Member, New Jersey Senate (Burlington)

HINJ honored Senator Allen for her nearly 22 years of distinguished legislative service that has earned her a reputation as being one of the most effective patient advocates in the New Jersey Senate.  In the past year alone, Senator Allen, who will retire from the Senate in January, authored laws relating to elder abuse; domestic violence; improved support for veterans challenged with addiction and mental health issues; and the expansion of telemedicine, which is revolutionizing patient access to health care. Continue reading

PhRMA’s Chief Medical Officer on ‘The Next Five Years of PDUFA VI: Driving the Availability of Innovative Treatments for Patients’

Dr. Bill Chin

Washington, DC, October 13, 2017William “Bill” Chin, M.D., who serves as the chief medical officer of Pharmaceutical Research and Manufacturers of America (PhRMA) and leads the Scientific & Regulatory Advocacy department as executive vice president, wrote the following on PhRMA’s blog, The Catalyst, on October 2:

Yesterday, October 1, marked the first day of implementation for PDUFA VI, the next iteration of the Prescription Drug User Fee Act (PDUFA) and one of the best tools that the U.S. Food and Drug Administration (FDA) has for enhancing regulatory efficiency and encouraging innovative development of safe and effective new medicines for patients.

First enacted in 1992, PDUFA allows the FDA to collect user fees from biopharmaceutical companies to help support the agency’s process for review of new drugs and biologics. Continue reading

WSJ Analysis Finds Nine of 10 Largest College STEM Programs Increased Share of Women Graduates

New York, NY, October 13, 2017 — Melissa Korn reports in The Wall Street Journal that as more high-paying jobs require a degree and expertise in things like computer coding or mechanical engineering, colleges and universities are racing to fill a pronounced void in qualified candidates.

One place they are making extra effort is among women.

The U.S. Labor Department estimates there will be 510,900 engineering job openings in the U.S. by 2024, and another 426,900 software development and programming jobs will be available, all requiring at least a bachelor’s degree. Continue reading

NIH Accelerates the Use of Genomics Sequencing in Clinical Care

Bethesda, MD, October 13, 2017 — The National Institutes of Health (NIH) on August 8 announced it is awarding $18.9 million towards research that aims to accelerate the use of genome sequencing in clinical care.

The new awards will generate innovative approaches and best practices to ensure that the effectiveness of genomic medicine can be applied to all individuals and groups, including diverse and underserved populations, and in healthcare settings that extend beyond academic medical centers. Continue reading

U.S. House Passes Bill Enhancing Small Business Innovation Research and Small Business Technology Transfer Programs

Westerville, OH, October 12, 2017 ― Jason Rittenberg reports on the State Science & Technology Institute (SSTI) news blog that the U.S. House this week passed H.R. 2763, which would amend the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs in several significant ways.

Most notably, the bill would extend by five years the “assistance for administrative… costs,” which is used for outreach initiatives and some business and market assistance initiatives across agencies.

The bill would extend or implement other activities within SBIR/STTR, nearly all of which would improve the programs’ ability to support commercialization in parallel with technological development. Continue reading

Eric Hargan Sworn In as Deputy Secretary of Health and Human Services Department

HHS Deputy Secretary Eric Hargan

Washington, DC, October 12, 2017 — The U.S. Department of Health and Human Services (HHS) announced that Eric Hargan has been sworn in as Deputy Secretary.

The U.S. Senate confirmed Mr. Hargan to fill the No. 2 position at HHS on October 4, just days after Secretary Tom Price resigned.

The 57-to-38 Senate vote was largely along party lines.  Seven Democrats and Sen. Angus King (I-Maine) supported the nomination, according to The Hill. Continue reading

PhRMA Announces 2017 Research & Hope Award Honorees; Releases ‘Medicines in Development for Mental Illnesses Report’

Washington, DC, October 11, 2017 — As part of Mental Health Awareness Week, Pharmaceutical Research and Manufacturers of America (PhRMA) yesterday announced it is recognizing and honoring five individuals who are working tirelessly to advocate for patients, fight stigma surrounding mental illnesses and advance research at our 2017 Research & Hope Awards.

In addition, PhRMA said that America’s biopharmaceutical companies are committed to alleviating the considerable burden of mental illness and bringing cutting-edge medicines and new treatments to patients.

According to a new report — “Medicines in Development for Mental Illnesses 2017 Report” — released on October 10, there are more than 140 medicines in development to treat mental illnesses such as anxiety, depression, schizophrenia and more. Continue reading

Hackensack University Medical Center Foundation Receives Donation from Celgene to Advance Multiple Myeloma Research at John Theurer Cancer Center

Former Roche campus to be new Seton Hall-Hackensack Meridian School of Medicine

Hackensack, NJ, October 11, 2017 — The Hackensack University Medical Center Foundation announced on October 5 that it has received a substantial donation from Celgene Corporation to advance multiple myeloma research and transformational medicine that improve patient outcomes at Hackensack Meridian Health–John Theurer Cancer Center.

Supported by Celgene, a global biopharmaceutical leader in the discovery, development and delivery of treatment for diseases like multiple myeloma (MM), funds will help to establish the Multiple Myeloma Institute (MMI) — a leading-edge research facility at the Seton Hall-Hackensack Meridian School of Medicine scheduled to open in 2018.

Celgene and John Theurer Cancer Center are accomplished leaders in developing novel therapies for patients with multiple myeloma. Continue reading